| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
A1BG antisense RNA 1 | 1.000 | 0.077 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
APOBEC1 complementation factor | 0.604 | 0.692 | 5.9E-10 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2019 | ||||||||
|
alpha-2-macroglobulin | 0.529 | 0.769 | 4.5E-11 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2014 | ||||||||
|
aortic aneurysm, familial abdominal 1 | 0.695 | 0.615 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | |||||||||
|
aladin WD repeat nucleoporin | 0.601 | 0.654 | 2.4E-13 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
ATP binding cassette subfamily A member 4 | 0.493 | 0.769 | 5.3E-48 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
phenotype | 0.100 | None | 1.000 | 33 | 0 | 1994 | 2020 | ||||||||
|
ATP binding cassette subfamily B member 5 | 0.623 | 0.538 | 1.5E-37 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 6 (Langereis blood group) | 0.431 | 0.885 | 8.6E-19 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
ATP binding cassette subfamily C member 1 | 0.445 | 0.808 | 1.2E-03 |
|
phenotype | 0.060 | None | 1.000 | 6 | 0 | 2012 | 2020 | ||||||||
|
ATP binding cassette subfamily C member 2 | 0.483 | 0.808 | 5.2E-47 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2013 | ||||||||
|
ATP binding cassette subfamily C member 3 | 0.517 | 0.769 | 1.2E-26 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2012 | 2018 | ||||||||
|
ATP binding cassette subfamily C member 5 | 0.606 | 0.654 | 4.2E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
ATP binding cassette subfamily C member 6 | 0.540 | 0.654 | 5.6E-35 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
ATP binding cassette subfamily E member 1 | 0.674 | 0.462 | 0.97 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2014 | 2015 | ||||||||
|
ATP binding cassette subfamily G member 1 | 0.560 | 0.692 | 0.11 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
ATP binding cassette subfamily G member 2 (Junior blood group) | 0.419 | 0.885 | 2.1E-32 |
|
phenotype | 0.100 | None | 1.000 | 18 | 0 | 2010 | 2020 | ||||||||
|
ATP binding cassette subfamily G member 5 | 0.592 | 0.577 | 3.1E-21 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
ABHD11 antisense RNA 1 (tail to tail) | 0.722 | 0.192 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 2018 | 2019 | |||||||||
|
abhydrolase domain containing 5 | 0.641 | 0.538 | 6.4E-07 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
abl interactor 1 | 0.641 | 0.538 | 0.64 |
|
phenotype | 0.060 | None | 1.000 | 6 | 0 | 2007 | 2019 | ||||||||
|
ABI family member 3 | 0.716 | 0.231 | 5.0E-05 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2008 | 2014 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2012 | 2018 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2014 |